Recon: Novo licenses Chinese biotech’s obesity candidate for up to $2B; 23andMe files for bankruptcy

• 23andMe filing for bankruptcy as CEO Anne Wojcicki resigns (STAT)
• Novo Nordisk expands discounted Wegovy to all cash-paying US customers (Reuters)
• Trump to nominate Susan Monarez for CDC director, elevating from acting role, sources say (CBS)
• US CDC Vaccines AdComm Rescheduled For April Without Influenza Vote (Pink Sheet)
• UBS Hires RBC Capital Biotech Bankers in US Health-Care Push (Bloomberg)
• Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects (Reuters)

• Novo licenses Chinese biotech's obesity drug candidate for up to $2 billion (Reuters)
• UK detects first case of bird flu in a sheep, stoking fears of spread (Reuters)
• Brazil's Hypera to launch an Ozempic generic in 2026, CEO says (Reuters)
• WHO calls for immediate action as report shows 10% rise in child TB infections in European region (Reuters)
• European regulators to review GSK's asthma drug Nucala to treat COPD (Reuters)
• Liver cancer drug combo gets second FDA rejection over manufacturing issues (Endpoints)
• EU Project Aims To Boost Drug Testing Reliability By Replacing Monkeys With Pigs (Pink Sheet)
• German Medtechs Up The Stakes On Amending Hospital Reform Law (MedTech Insight)

• Philanthropy can help create a healthier biotech ecosystem (STAT)
• Biogen plans to open new headquarters in Boston area in 2028 (Endpoints)
• Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders (Endpoints)
• Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills (Endpoints)
• SV Health Investors nabs $250M to fund dementia-focused biotechs (Endpoints)
• Novartis' Fabhalta nod in C3G leaves room for rival Apellis (Fierce Pharma)

• Why HCA is ‘all in’ on surgical robotics (MedTech Dive)
• J&J boosts planned US manufacturing investment to $55B (MedTech Dive)
• Smiths Medical recalls port implants, warns on endotracheal tubes (MedTech Dive)
• FDA posts early alert after Calyxo urinary stone device tied to death (MedTech Dive)
• European Medicine Agency’s CHMP Qualifies First AI Tool For Use In Clinical Trials (MedTech Insight)
• Barcelona’s S2 Xpeed Accelerates Hardware-Based Medtech Start-Ups From Prototype To Market (MedTech Insight)
• Urgent Call for Leadership In EU Medtech To Steer Through Regulatory Challenges (MedTech Insight)

• Trump admin delays traceability rule to contain foodborne illness outbreaks (Food Dive)
• US turns to Brazil for eggs and considers other sources during bird flu outbreak (Reuters)
• Researchers Explore How Biases Affect Food Safety Management Systems, Suggest Supply Chain-Wide Culture Focus (Food Safety)
• Researchers Explore AI Analysis of WGS Data for Foodborne Illness Source Attribution (Food Safety)
• Canadian Chicken Study Finds Resistance to Important Antibiotics in Salmonella, Campylobacter (Food Safety)

• Five years ago, early career researchers needed help to survive the pandemic. Now they need it again (STAT)
• Lawmakers are pushing the HALT Fentanyl Act as the solution to the overdose crisis. Experts warn it will fall short (STAT)
• Cancer research, long protected, feels ‘devastating’ effects under Trump (STAT)
• Calley Means joins White House as a special government employee, will assist with MAHA policies (Endpoints)
• Testosterone, TRAVERSE, And A Label Change 15 Years In The Making (Pink Sheet)
• No ACNU Yet; Effective Date Delayed Again (FDA Law Blog)